Skip to main content

Childhood Cancer and Blood Disorders

The research group is focused on finding new molecular therapeutic targets and biomarkers based on knowledge of the biology of paediatric tumours, leukemias and hematologic diseases. The experience of the group in recent years has permitted the identification of new molecular targets that are very close to the clinical phase. In this stage, we have consolidated collaborations with the biotechnological industry in order to develop small molecules able to inhibit pro-oncogenic processes such as invasion or proliferation, with the aim of providing patients with innovative and more specific biological evidence-based therapies.

Another line of research is based on the study of liquid biopsy to develop a system based on NGS to monitor the probability of relapses.

Furthermore, we have implemented a personalized medicine program to guide the management of patients based on the molecular alterations of their tumours

Publications

TALAPRO-3 clinical trial protocol: phase III study of talazoparib plus enzalutamide in metastatic castration-sensitive prostate cancer.

PMID: 37882449
Journal: Future Oncology
Year: 2023
Reference: Future Oncol. 2023 Oct 26. doi: 10.2217/fon-2023-0526.
Impact factor:
Publication type: Paper in international publication
Authors: Agarwal, Neeraj; Alonso, Lucia; Azad, Arun A; Bordas, Anna; Casabona, Jordi; Chakrabarti, Jayeta; Chen, Hsiang-Chun; Colom-Cadena, Andreu; Fizazi, Karim; Ganem, Fabiana et al.
DOI: 10.2217/fon-2023-0526

Pralsetinib in patients with RET fusion-positive non-small cell lung cancer: A plain language summary of the ARROW study.

PMID: 37916501
Journal: Future Oncology
Year: 2023
Reference: Future Oncol. 2023 Nov 2. doi: 10.2217/fon-2023-0155.
Impact factor:
Publication type: Paper in international publication
Authors: Baik, Christina S; Boral, Andy L; Bowles, Daniel W; Chakravorty, Subarna; Colombatti, Raffaella; Curigliano, Giuseppe; de Montalembert, Mariane; Del Mar Manu Pereira, Maria; Gainor, Justin F; Garralda, Elena et al.
DOI: 10.2217/fon-2023-0155

Formation of an invasion-permissive matrix requires TGFbeta/SNAIL1-regulated alternative splicing of fibronectin.

PMID: 37964360
Journal: BREAST CANCER RESEARCH
Year: 2023
Reference: Breast Cancer Res. 2023 Nov 14;25(1):143. doi: 10.1186/s13058-023-01736-y.
Impact factor:
Publication type: Paper in international publication
Authors: Baulida, Josep; Benitez-Carbante, Maria Isabel; Benitez-Carbante, Maria Isabel; Diaz de Heredia, Cristina; Eyras, Eduardo; Fernandez Ledesma, Berta; Fernandez Ledesma, Berta; Fernandez-Polo, Aurora; Franco-Valls, Hector; Garcia de Herreros, Antonio et al.
DOI: 10.1186/s13058-023-01736-y

Developmental epileptic encephalopathy in DLG4-related synaptopathy.

PMID: 38135915
Journal: EPILEPSIA
Year: 2023
Reference: Epilepsia. 2023 Dec 22. doi: 10.1111/epi.17876.
Impact factor:
Publication type: Paper in international publication
Authors: Aledo-Serrano, Angel; Ananth, Amitha L; Brea-Fernandez, Alejandro J; Caumes, Roseline; Chatron, Nicolas; Dainelli, Alice; De Wachter, Matthias; Denomme-Pichon, Anne-Sophie; Dye, Thomas J; Fazzi, Elisa et al.
DOI: 10.1111/epi.17876

Minimally invasive surgery for neuroblastic tumours: A SIOPEN multicentre study: Proposal for guidelines.

PMID: 34489122
Journal: EJSO
Year: 2022
Reference: Eur J Surg Oncol. 2022 Jan;48(1):283-291. doi: 10.1016/j.ejso.2021.08.013. Epub 2021 Aug 16.
Impact factor:
Publication type: Paper in international publication
Authors: Basta, N; Bjornland, K; Cross, K; Faraj, S; Froeba-Pohl, A; Fuchs, J; Gabra, H O; Gomez Chacon Villalba, J; Guerin, F; Guillen Burrieza, G et al.
DOI: 10.1016/j.ejso.2021.08.013

Post-hematopoietic stem cell transplant squamous cell carcinoma in patients with Fanconi anemia: a dreadful enemy.

PMID: 34417960
Journal: Clinical & Translational Oncology
Year: 2022
Reference: Clin Transl Oncol. 2022 Feb;24(2):388-392. doi: 10.1007/s12094-021-02693-8. Epub 2021 Aug 21.
Impact factor:
Publication type: Paper in international publication
Authors: Balmana, J; Carrasco, E; de Pablo Garcia-Cuenca, A; Diaz-de-Heredia, C; Lorente Guerrero, J; Murillo-Sanjuan, L; Uria Oficialdegui, M L et al.
DOI: 10.1007/s12094-021-02693-8

Methodological advances in the discovery of novel neuroblastoma therapeutics.

PMID: 34807782
Journal: Expert Opinion on Drug Discovery
Year: 2022
Reference: Expert Opin Drug Discov. 2022 Feb;17(2):167-179. doi: 10.1080/17460441.2022.2002297. Epub 2021 Nov 22.
Impact factor:
Publication type: Review in international publication
Authors: Boloix, Ariadna; Canete, Adela; Cerda-Alberich, Leonor; Fletcher, Jamie I; Gallego, Soledad; Gray, Juliet C; Haber, Michelle; Jimenez, Carlos; Martinez de Las Heras, Blanca; Moreno, Lucas et al.
DOI: 10.1080/17460441.2022.2002297

Resilient health care in global pediatric oncology during the COVID-19 pandemic.

PMID: 34767629
Journal: CANCER
Year: 2022
Reference: Cancer. 2022 Feb 15;128(4):797-807. doi: 10.1002/cncr.34007. Epub 2021 Nov 12.
Impact factor:
Publication type: Paper in international publication
Authors: Agulnik, Asya; Alcasabas, Ana Patricia; Arce, Daniela; Arora, Ramandeep Singh; Gassant, Pascale Y; Graetz, Dylan E; Huang, Haiying; Kambugu, Joyce; Kaye, Erica C; Laptsevich, Aliaksandra et al.
DOI: 10.1002/cncr.34007

[Experience of the Spanish Group for Hematopoietic Transplantation (GETMON-GETH) in allogenic hematopoietic stem cell transplantation in Philadelphia acute lymphoblastic leukemia].

PMID: 33781716
Journal: ANALES DE PEDIATRIA
Year: 2021
Reference: An Pediatr (Engl Ed). 2021 Mar 26:S1695-4033(21)00148-X. doi: 10.1016/j.anpedi.2021.02.015.
Impact factor:
Publication type: Paper in national publication
Authors: Badell Serra, Isabel; de la Fuente Regano, Lydia; Diaz de Heredia Rubio, Cristina; Fernandez, Jose Maria; Galan Gomez, Victor; Gonzalez Vicent, Marta; Lopez Duarte, Monica; Maldonado Regalado, M Soledad; Pascual Martinez, Antonia Isabel; Perez Hurtado, Jose Maria et al.
DOI: 10.1016/j.anpedi.2021.02.015

A Phase I study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study).

PMID: 33067614
Journal: BLOOD
Year: 2021
Reference: Blood. 2021 Mar 25;137(12):1582-1590. doi: 10.1182/blood.2020007848.
Impact factor:
Publication type: Paper in international publication
Authors: Ammerlaan, Anneke Cj; Bielorai, Bella; Brethon, Benoit; Brivio, Erica; Chen, Ying; Chen-Santel, Christiane; Den Boer, Monique L; Diaz de Heredia, Cristina; Locatelli, Franco; Lopez-Yurda, Marta et al.
DOI: 10.1182/blood.2020007848

Recommendations for screening, monitoring, prevention, and prophylaxis of infections in adult and pediatric patients receiving CAR T-cell therapy: a position paper.

PMID: 32979154
Journal: INFECTION
Year: 2021
Reference: Infection. 2021 Apr;49(2):215-231. doi: 10.1007/s15010-020-01521-5. Epub 2020 Sep 26.
Impact factor:
Publication type: Review in international publication
Authors: Aguilar-Guisado, Manuela; Alsina-Manrique, Laia; Barba, Pere; Diaz de Heredia, Cristina; Fortuny-Guasch, Claudia; Garcia-Cadenas, Irene; Garcia-Vidal, Carolina; Gonzalez-Vicent, Marta; Hernani, Rafael; Iacoboni, Gloria et al.
DOI: 10.1007/s15010-020-01521-5

Use of eltrombopag for the treatment of poor graft function after hematopoietic stem cell transplantation in children.

PMID: 33742757
Journal: PEDIATRIC TRANSPLANTATION
Year: 2021
Reference: Pediatr Transplant. 2021 Jun;25(4):e14010. doi: 10.1111/petr.14010. Epub 2021 Mar 20.
Impact factor:
Publication type: Letter whit IF
Authors: Alonso, Laura; Benitez-Carabante, M Isabel; Diaz-de-Heredia, Cristina; Oliveras, Maria; Renedo, Berta; Uria-Oficialdegui, M Luz et al.
DOI: 10.1111/petr.14010

Transforming growth factor beta (TGF-beta) activity in immuno-oncology studies.

PMID: 32178817
Journal: Methods in Enzymology
Year: 2020
Reference: Methods Enzymol. 2020;636:129-172. doi: 10.1016/bs.mie.2019.06.008. Epub 2019 Jul 12.
Impact factor:
Publication type: Paper in international publication
Authors: Aranda, Fernando; Di Scala, Marianna; Dotor, Javier; Gallo-Oller, Gabriel et al.
DOI: 10.1016/bs.mie.2019.06.008

Pediatric acute graft-versus-host disease prophylaxis and treatment: Real-life approach reveals dissimilarities compared to published recommendations.

PMID: 32133691
Journal: TRANSPLANT INTERNATIONAL
Year: 2020
Reference: Transpl Int. 2020 Jul;33(7):762-772. doi: 10.1111/tri.13601. Epub 2020 Apr 2.
Impact factor:
Publication type: Paper in international publication
Authors: Bader, P; Balduzzi, A; Bauer, D; Bordon, V; Corbacioglu, S; Dalissier, A; Dalle, J-H; Diaz De Heredia, C; Gibson, B; Lawitschka, A et al.
DOI: 10.1111/tri.13601

miRNA-7 and miRNA-324-5p regulate alpha9-Integrin expression and exert anti-oncogenic effects in rhabdomyosarcoma.

PMID: 32142919
Journal: CANCER LETTERS
Year: 2020
Reference: Cancer Lett. 2020 May 1;477:49-59. doi: 10.1016/j.canlet.2020.02.035. Epub 2020 Mar 3.
Impact factor:
Publication type: Paper in international publication
Authors: Gallego, S; Gallo-Oller, G; Garrido, M; Giralt, I; Guillen, G; Hladun, R; Magdaleno, A; Molist, C; Moreno, L; Navarro, N et al.
DOI: 10.1016/j.canlet.2020.02.035

Update of the Spanish registry of haemoglobinopathies in children and adults.

PMID: 32113697
Journal: MEDICINA CLINICA
Year: 2020
Reference: Med Clin (Barc). 2020 Aug 14;155(3):95-103. doi: 10.1016/j.medcli.2019.10.011. Epub 2020 Feb 26.
Impact factor:
Publication type: Paper in national publication
Authors: Argiles, Bienvenida; Bardon Cancho, Eduardo J; Belendez, Cristina; Beneitez, David; Bermudez, Mar; Berrueco, Ruben; Cela, Elena; Cervera, Aurea; Garcia-Morin, Marina; Gondra, Ainhoa et al.
DOI: 10.1016/j.medcli.2019.10.011

Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial.

PMID: 31562043
Journal: LANCET ONCOLOGY
Year: 2019
Reference: Lancet Oncol. 2019 Nov;20(11):1566-1575. doi: 10.1016/S1470-2045(19)30617-5. Epub 2019 Sep 24.
Impact factor: 35.386
Publication type: Paper in international publication
Authors: Devalck, Christine, Ben-Arush, Myriam, Mudry, Peter, Ferman, Sima, Jenney, Meriel, Ferrari, Andrea, Zanetti, Ilaria, Casanova, Michela, Glosli, Heidi, Bisogno, Gianni et al.
DOI: 10.1016/S1470-2045(19)30617-5

Successful treatment of post-transplant CMV meningoencephalitis with third-party CMV virus-specific T cells: Lessons learned.

PMID: 31556188
Journal: PEDIATRIC TRANSPLANTATION
Year: 2019
Reference: Pediatr Transplant. 2019 Dec;23(8):e13584. doi: 10.1111/petr.13584. Epub 2019 Sep 26.
Impact factor: 1.326
Publication type: Paper in international publication
Authors: Querol, Sergio, Alonso, Laura, Rudilla, Francesc, Gimeno, Ramon, Codinach, Margarita, Blanco, Margarita, Diaz de Heredia, Cristina et al.
DOI: 10.1111/petr.13584

A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations.

PMID: 31543384
Journal: EUROPEAN JOURNAL OF CANCER
Year: 2019
Reference: Eur J Cancer. 2019 Nov;121:224-235. doi: 10.1016/j.ejca.2019.07.027. Epub 2019 Sep 19.
Impact factor: 6.68
Publication type: Paper in international publication
Authors: George, Sally L, Izquierdo, Elisa, Campbell, James, Moreno, Lucas, Pearson, Andrew, Shipley, Janet, Jones, Chris, Hargrave, Darren, Jacques, Thomas S, Hubank, Michael et al.
DOI: 10.1016/j.ejca.2019.07.027

Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia.

PMID: 31501599
Journal: NATURE MEDICINE
Year: 2019
Reference: Nat Med. 2019 Sep;25(9):1396-1401. doi: 10.1038/s41591-019-0550-z. Epub 2019 Sep 9.
Impact factor: 30.641
Publication type: Paper in international publication
Authors: Rio, Paula, Navarro, Susana, Wang, Wei, Sanchez-Dominguez, Rebeca, Pujol, Roser M, Segovia, Jose C, Bogliolo, Massimo, Merino, Eva, Wu, Ning, Salgado, Rocio et al.
DOI: 10.1038/s41591-019-0550-z

Prognostic relevance of early radiologic response to induction chemotherapy in pediatric rhabdomyosarcoma: A report from the International Society of Pediatric Oncology Malignant Mesenchymal Tumor 95 study.

PMID: 29211298
Journal: CANCER
Year: 2018
Reference: Cancer. 2018 Mar 1;124(5):1016-1024. doi: 10.1002/cncr.31157. Epub 2017 Dec 6.
Impact factor: 6.537
Publication type: Paper in international publication
Authors: Vaarwerk, Bas, van der Lee, Johanna H, Breunis, Willemijn B, Orbach, Daniel, Chisholm, Julia C, Cozic, Nathalie, Jenney, Meriel, van Rijn, Rick R, McHugh, Kieran, Gallego, Soledad et al.
DOI: 10.1002/cncr.31157

An Integrative Scoring System for Survival Prediction Following Umbilical Cord Blood Transplantation in Acute Leukemia.

PMID: 28754820
Journal: CLINICAL CANCER RESEARCH
Year: 2017
Reference: Clin Cancer Res. 2017 Nov 1;23(21):6478-6486. doi: 10.1158/1078-0432.CCR-17-0489. Epub 2017 Jul 28.
Impact factor: 9.619
Publication type: Paper in international publication
Authors: Shouval, Roni, Ruggeri, Annalisa, Labopin, Myriam, Mohty, Mohamad, Sanz, Guillermo, Michel, Gerard, Kuball, Jurgen, Chevallier, Patrice, Al-Seraihy, Amal, Milpied, Noel-Jean et al.
DOI: 10.1158/1078-0432.CCR-17-0489

Fertility preservation issues in pediatric hematopoietic stem cell transplantation: practical approaches from the consensus of the Pediatric Diseases Working Party of the EBMT and the International BFM Study Group.

PMID: 28737775
Journal: BONE MARROW TRANSPLANTATION
Year: 2017
Reference: Bone Marrow Transplant. 2017 Oct;52(10):1406-1415. doi: 10.1038/bmt.2017.147. Epub 2017 Jul 24.
Impact factor: 3.874
Publication type: Paper in international publication
Authors: Ahler, A, Balduzzi, A, Dalle, J-H, Jahnukainen, K, von Wolff, M, Lucchini, G, Ifversen, M, Macklon, K T, Poirot, C, Diesch, T et al.
DOI: 10.1038/bmt.2017.147

Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia.

PMID: 28557976
Journal: BRITISH JOURNAL OF CANCER
Year: 2017
Reference: Br J Cancer. 2017 Jul 11;117(2):256-265. doi: 10.1038/bjc.2017.152. Epub 2017 May 30.
Impact factor: 6.176
Publication type: Paper in international publication
Authors: Forero-Castro, Maribel, Robledo, Cristina, Benito, Rocio, Bodega-Mayor, Irene, Rapado, Inmaculada, Hernandez-Sanchez, Maria, Abaigar, Maria, Maria Hernandez-Sanchez, Jesus, Quijada-Alamo, Miguel, Maria Sanchez-Pina, Jose et al.
DOI: 10.1038/bjc.2017.152

Factors Associated with Long-Term Risk of Relapse after Unrelated Cord Blood Transplantation for Children with Acute Lymphoblastic Leukemia in Remission.

PMID: 28438676
Journal: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Year: 2017
Reference: Biol Blood Marrow Transplant. 2017 Aug;23(8):1350-1358. doi: 10.1016/j.bbmt.2017.04.015. Epub 2017 Apr 21.
Impact factor: 4.704
Publication type: Paper in international publication
Authors: Page, Kristin M, Labopin, Myriam, Ruggeri, Annalisa, Michel, Gerard, Diaz de Heredia, Cristina, O'Brien, Tracey, Picardi, Alessandra, Ayas, Mouhab, Bittencourt, Henrique, Vora, Ajay J et al.
DOI: 10.1016/j.bbmt.2017.04.015

Blog

News

The association, once again, has shown its commitment to oncological research with a donation of €19,197 to the Cancer and Hematological Diseases Group for Children at VHIR.

The prestigious journal The Lancet has published the results of this study, which is the result of more than 20 years of pre-clinical research and 7 years of patient follow-up.

During the meeting, the role of the Vall d'Hebron Paediatric Research Hub in promoting research on children and adolescents was highlighted.